Thymalin vs Vilon
How Thymalin and Vilon compare — what each is, how strong the human evidence is for each, doses reported in research, the key risks, and 2026 US legal status. No universal winner.
Thymalin and Vilon come up together when people are weighing similar options. Here's the honest side-by-side: what each is, how strong the human evidence is for each, the doses reported in research, the risks, and where each stands with the FDA as of 2026. There's no universal winner — scroll to the by-goal picks for which one fits which goal.
Thymalin vs Vilon, point by point
Every dimension side by side — the honest differences, not a scoreboard.
| Dimension | Thymalin | Vilon |
|---|---|---|
| What it is | Thymus-derived polypeptide preparation (an immunomodulator; chemical databases also index it under the thymulin/nonathymulin nonapeptide) | Synthetic dipeptide bioregulator made from lysine and glutamic acid |
| Class / category | Longevity / mitochondrial | Longevity / mitochondrial |
| Evidence tier | Human (controlled) · Mixed | Animal-only · Unclear · none in humans |
| Studied / approved for | Immune restoration / secondary immunodeficiency; Healthy aging / geroprotection | Longevity and age-related biology; Immune-cell signaling |
| US regulatory status (2026) | research use only (as of Jul 2026) | research use only (as of Jul 2026) |
| Doses reported in research | No established study doses | No established study doses |
| Registered trials (ClinicalTrials.gov) | 0 | No data |
| Banned in sport (WADA) | No | Yes — on the WADA prohibited list |
| Key risks | Thymalin has an unusually long clinical-use history — decades as a registered immunomodulator in Russia — where it was generally described as well tolerated. That track record is reassuring but not the same as modern long-term safety data, which is thin by Western standards. Because thymalin is extracted from animal thymus tissue rather than chemically synthesized, it also carries the theoretical concerns of any tissue-derived biologic: allergic or immune reactions and contamination if purification is poor. In the US it is sold as an unregulated research chemical, so purity, dose accuracy and sterility vary by vendor. | Vilon has no modern, well-reported human safety program, so its adverse-event rate, interactions, pharmacokinetics and long-term risks are unknown. Cell and mouse tolerability cannot establish human safety. Research-market products add separate uncertainty about identity, purity, dose accuracy and sterility. |
- Evidence tier: A tier reflects how human the evidence is, not a promise the compound works.
Thymalin vs Vilon: the two molecules
The 2D chemical structures, straight from PubChem — a quick way to see how similar (or not) the two actually are.
Which one fits which goal?
There's no universal winner here — the honest answer depends on what you're after. These picks are framed by goal, and each says why.
If you want the option with more human evidence behind it
Leans toward Thymalin
Thymalin's evidence sits at human (controlled), a more human tier than Vilon's animal-only. That reflects how the data was gathered, not a guarantee it works.
References
- 1.Thymalin — indexed research (PubMed, National Library of Medicine)
- 2.Thymalin — human-tagged clinical research (PubMed filter)
- 3.Thymalin compound record (PubChem CID 3085284)
- 4.Thymalin — registered clinical studies (ClinicalTrials.gov)
- 5.FDA — drug approval information
- 6.PubChem — Lysylglutamic acid (Vilon), CID 7010502